Epcoritamab in Previously Treated WM

Summary

This study is being done to determine if epcoritamab can be used to treat participants with previously treated Waldenstrom Macroglobulinemia (WM). The names of the study drug involved in this study is: -Epcoritamab (a type of antibody)

Timeline

Start

2024-12-06

Primary completion

2027-04-30

Completion

2027-12-31

Drugs

Indications